By Bhanvi Satija LONDON, April 1 (Reuters) - Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated ...
Pfizer BioNTech halt COVID vaccine study in adults 50-64 due to slow enrollment, citing inability to generate relevant postmarketing data.
Doctors break down what you need to know about the four-dose vaccine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results